Professor Robert Perneczky
MD MBA
Neuroscience, School of Medicine and Population Health
Chair in Translational Dementia Research
r.perneczky@sheffield.ac.uk
+44 114 222 2295
+44 114 222 2295
91Ö±²¥ Institute for Translational Neuroscience (SITraN)
Full contact details
Professor Robert Perneczky
Neuroscience, School of Medicine and Population Health
91Ö±²¥ Institute for Translational Neuroscience (SITraN)
385a Glossop Road
91Ö±²¥
S10 2HQ
Neuroscience, School of Medicine and Population Health
91Ö±²¥ Institute for Translational Neuroscience (SITraN)
385a Glossop Road
91Ö±²¥
S10 2HQ
- Profile
-
- 2022-present: Professor of Translational Dementia Research, University of 91Ö±²¥, 91Ö±²¥, UK
- 2016-present: Professor/Head of Division of Old Age Psychiatry, Ludwig-Maximilians-University Munich/University Hospital LMU Munich, Germany
- 2016-present: PI/Research group leader, German Center for Neurodegenerative Diseases (DZNE) Munich, Germany
- 2012-2018: Reader in Dementia Research/Co-Head of Department/Consultant Psychiatrist, Imperial College London, School of Public Health, London, UK
- 2002-2013: Assistant doctor/consultant psychiatrist, Technical University Munich, Department of Psychiatry, Munich, Germany
- 2001: Qualification at Technical University Munich, Germany
- Research interests
-
- Alzheimer’s disease fluid biomarkers (blood, CSF, RNA)
- Neuroimaging (MRI, PET)
- Neuroepidemiology
- Pharmacological and non-pharmacological prevention/treatment of dementia
- Frontotemporal dementia, atypical Parkinson’s disease
- Healthcare preparedness in dementia
- Teaching interests
-
Old age psychiatry
- Professional activities and memberships
-
- Member of the German memory clinics network executive board
- Member of the University of 91Ö±²¥ BRC executive board
- Member of the University of 91Ö±²¥, Neuroscience Flagship Institute executive board (Translational Neuroscience theme co-lead)
- Current Projects
- Mechanisms of Amyloid Clearance in Alzheimer’s disease and other neurodegenerative diseases (AmyClear), funded by VERUM Foundation, Germany and University of 91Ö±²¥ BRC
- Activity of Cerebral Networks, Amyloid and Microglia in Aging and Alzheimer’s disease (ActiGliA), funded by German Excellence Initiative and German Center for Neurodegenerative Disorders
- Non-pharmacological treatment of challenging behaviour in dementia, funded by Robert-Vogel-Foundation, Germany